[13] Zou CC, et al. Type 1 diabetes mellitus associated with phenobarbital hypersensitivity syndrome: one case report and literature review. J Endocrinol Invest 2008; 31(4):360-63.
[14] Zou CC, et al. Peripheral precocious puberty: A retrospective study for six years in Hangzhou, China. J Paediatr Child Health 2008; 44(7): 415-8.
[15] Fu JF, Liang L, Zou CC, et al. Prevalence of the metabolic syndrome in Zhejiang Chinese obese children and adolescents and the effect of metformin combined with lifestyle intervention. Int J Obes (Lond) 2007; 31(1):15-22.
[16] Zou CC, et al. Relationship between insulin resistance and serum levels of adiponectin and resistin with childhood obesity. Indian Pediatr 2007; 44(4):275-9.
[17] Wu F, Zou CC. Childhood Weber-Christian disease: clinical investigation and virus detection. Acta Paediatrica 2007; 96(11):1665-9.
[18] Zou CC, et al. Clinical and molecular analysis of NF-kappaB essential modulator in Chinese incontinentia pigmenti patients. Int J Dermatol 2007; 46(10): 1017-22.
[19] Zou CC, et al. Plasma levels of matrix metalloproteinase-9 in Henoch-Schönlein purpura. Scand J Rheumatol 2006; 35(1):52-5.
52667788.cn[20] Zou CC, et al. Primary abdominal lymphonudular cryptococcosis in children: two cases report and literature review. J Pediatr Surg 2006; 41(3):e11-5.
[21] YU ZS, Zou CC (通訊), et al. Cytomegalovirus gB genotype and clinical feature in Chinese infants with congenital infection. Intervirology 2006; 49(5):281-5.
[22] Zou CC, et al. Multiple hypoechoic lesions in spleen and Mycoplasma Pneumoniae infection. Indian Pediatr 2005; 42(4):379-82.
[23] Zou CC, et al. Serum adiponectin, resistin levels and non-alcoholic fatty liver disease in obese children. Endocrin J 2005; 52(5):519-24.
[24] Zou C, et al. Methylenetetrahydrofolate reductase (MTHFR) polymorphism in childhood primary focal segmental glomerulosclerosis. Nephron 2002; 92:449-51.
2. 主持和主要參與課題
[1] 主持省衛(wèi)生廳課題《
鉛對(duì)兒童視覺(jué)和聽(tīng)覺(jué)誘發(fā)電位的影響》，項(xiàng)目編號(hào)2003B103，起止時(shí)間2003-2006
[2] 參與（第2)省計(jì)生委課題《特發(fā)性矮小兒童
生長(zhǎng)激素受體基因多態(tài)性研究》，項(xiàng)目編號(hào)[2003]101，起止時(shí)間2003-2006
[3] 參與（第2)省教育廳課題《ICPP女童心理行為變化與甾體激素關(guān)系的研究》，項(xiàng)目編號(hào)20040213，起止時(shí)間2004-2007
[4] 主持教育廳課題《血漿ghrelin水平和ghrelin基因多態(tài)性與兒童
肥胖癥的關(guān)系》，項(xiàng)目編號(hào)20050969，起止時(shí)間2005-2007
[5] 主持省計(jì)生委課題《持續(xù)血糖檢測(cè)系統(tǒng)（CGMS)在肥胖癥兒童和青少年糖代謝檢測(cè)中的應(yīng)用》， 起止時(shí)間2006-2007
[6] 主持省衛(wèi)生廳課題《矮小癥兒童血漿ghrelin水平和ghrelin基因多態(tài)性的初探》，項(xiàng)目編號(hào)2006QN017，起止時(shí)間2006-2008
[7] 參與（第2)省科技廳重大課題《青少年肥胖、代謝綜合征綜合防治平臺(tái)的建設(shè)》
52667788.cn，項(xiàng)目編號(hào)2008C03002-1，起止時(shí)間2008-2011
3. 獲獎(jiǎng)情況
[1] 參與課題（第4)《兒童
鉛中毒的
流行病學(xué)調(diào)查和臨床研究》獲2006年浙江省醫(yī)藥衛(wèi)生科技創(chuàng)新獎(jiǎng)一等獎(jiǎng)和省政府科技進(jìn)步二等獎(jiǎng)
[2] 參與課題（第5)《肥胖兒童
胰島素抵抗發(fā)病機(jī)制及治療新方法的研究》獲2008年浙江省醫(yī)藥衛(wèi)生科技創(chuàng)新獎(jiǎng)一等獎(jiǎng)和省政府科技進(jìn)步二等獎(jiǎng)
[3] 參與課題（第6)《孕母患自身免疫性甲狀腺疾病對(duì)嬰兒影響的多因素分析》獲2007浙江省醫(yī)藥衛(wèi)生科技創(chuàng)新獎(jiǎng)二等獎(jiǎng)
[4] 主持項(xiàng)目《矮小癥兒童血漿ghrelin水平和ghrelin基因多態(tài)性的初探》獲2009年浙江省醫(yī)藥衛(wèi)生科技創(chuàng)新獎(jiǎng)二等獎(jiǎng)
上一頁(yè) [1] [2] [3] 下一頁(yè)
